In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...

Treating antiphospholipid syndrome by focusing on blood clots falls short of addressing the underlying biology driving each individual patient's disease ...

Red-fleshed kiwifruit, valued for its high anthocyanin content and associated health benefits, is increasingly threatened by ...

10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 2026 10x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19. Operator: Thank you ...

A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can ...

Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood ...

In a new study, an aging clock has revealed neuron-specific aging, as well as potentially neuroprotective compounds.

High above the rivers of Madagascar, a small arachnid is quietly rewriting what I thought was possible in nature. The Darwin’s bark spider, already famous for its giant orb webs, has now been ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $166 million. The company expects the full year’s ...